Latest

Alnylam Wins $25 Million Milestone as Regeneron’s Livsayis Secures FDA Approval Alnylam Pharmaceuticals (NASDAQ: ALNY) said Regeneron received FDA approval

Alnylam Pharmaceuticals (NASDAQ: ALNY) said Regeneron received FDA approval for Livsayis (cemdisiran) to treat adults with anti-AChR antibody-positive generalized myasthenia gravis, marking the first...

11-19-26

Block’s Square Partners With NAB to Expand Business Banking Integration in Australia Block (NYSE: XYZ) announced a partnership between Square

Block (NYSE: XYZ) announced a partnership between Square Australia and National Australia Bank aimed at simplifying payments and cash-flow management for Australian businesses. The...

11-19-26

Zoetis Wins USDA License for 3-in-1 Poultry Vaccine Zoetis (NYSE: ZTS) received a U.S. Department of Agriculture license for Poulvac

Zoetis (NYSE: ZTS) received a U.S. Department of Agriculture license for Poulvac Procerta HVT-ND-ILT, a new vector vaccine designed to protect chickens against Marek’s...

11-19-26

Palo Alto Networks to Acquire Applied Compute in $4.5 Billion AI Deal Palo Alto Networks (NASDAQ: PANW) entered into a

(NASDAQ: PANW) entered into a definitive agreement to acquire Applied Compute in an all-stock transaction valued at $4.5 billion, expanding its...

11-19-26

Lockheed Martin F-35C Completes First Ford-Class Carrier Launch and Recovery Tests Lockheed Martin (NYSE: LMT) said its F-35C Lightning II

Lockheed Martin (NYSE: LMT) said its F-35C Lightning II completed its first launch-and-recovery testing aboard a Gerald R. Ford-class aircraft carrier, marking a major...

11-19-26

Uber Eats Adds Auto Parts Delivery Through AutoParts*com Partnership Uber Technologies (NYSE: UBER) expanded its retail marketplace by partnering with

Uber Technologies (NYSE: UBER) expanded its retail marketplace by partnering with AutoParts*com, bringing automotive parts to Uber Eats for the first time. The partnership...

11-19-26

Abbott Starts VOYAGER Trial for Software-Guided Encantor TAVI System Abbott (NYSE: ABT) initiated the VOYAGER CE clinical trial evaluating its

Abbott (NYSE: ABT) initiated the VOYAGER CE clinical trial evaluating its investigational Encantor balloon-expandable transcatheter aortic valve implantation system for patients with symptomatic severe...

11-19-26

Microchip Expands RT PolarFire FPGA Portfolio With New Spaceflight Qualifications Microchip Technology (NASDAQ: MCHP) expanded its radiation-tolerant PolarFire FPGA portfolio

Microchip Technology (NASDAQ: MCHP) expanded its radiation-tolerant PolarFire FPGA portfolio with new spaceflight qualifications aimed at high-reliability aerospace and defense applications. The RT PolarFire...

11-19-26

Johnson & Johnson Begins Commercial Launch of OTTAVA Surgical Robot With First U.S. Installation Johnson & Johnson (NYSE: JNJ) announced

Johnson & Johnson (NYSE: JNJ) announced the first commercial installation of its OTTAVA robotic surgical system at Memorial Hermann-Texas Medical Center in Houston, marking...

11-19-26

Merck Partners With Isomorphic Labs to Use AI in Oncology Drug Discovery Merck (NYSE: MRK) entered a strategic research collaboration

Merck (NYSE: MRK) entered a strategic research collaboration with Isomorphic Labs to discover small-molecule drug candidates against an oncology target, combining Merck’s proprietary data...

11-19-26

National Bank Financial Upgrades TELUS to Outperform National Bank Financial upgraded TELUS (NYSE: TU) to Outperform from Sector Perform. TELUS

upgraded TELUS (NYSE: TU) to Outperform from Sector Perform. TELUS shares are indicated at $10.57, up 11.1%, following the upgrade. The...

11-19-26

Barclays Initiates Synopsys at Overweight With $640 Price Target Barclays initiated coverage of Synopsys (NASDAQ: SNPS) with an Overweight rating,

Barclays initiated coverage of Synopsys (NASDAQ: SNPS) with an Overweight rating, with analyst Saket Kalia setting a $640 price target. Synopsys shares are at...

11-19-26

NYSE:PANW

Post Image
Palo Alto Networks to Acquire Applied Compute in $4.5 Billion AI Deal

Palo Alto Networks (NASDAQ: PANW) entered into a definitive agreement to acquire Applied Compute in an all-stock transaction valued at $4.5 billion, expanding its strategy beyond cybersecurity into secure enterprise AI infrastructure.

Applied Compute provides post-training and inference technology for open-weight AI models. Palo Alto Networks plans to combine the platform with its security capabilities so enterprises can train, adapt and deploy open-source and open-weight models securely across public cloud and sovereign environments.

The acquisition also brings Applied Compute’s AI research team into Palo Alto Networks. Co-founder and CEO Yash Patil is expected to become Co-Chief AI Officer after closing, while the team will help embed AI more broadly across Palo Alto’s products and proprietary models.

The deal strengthens Palo Alto Networks’ position at the intersection of cybersecurity and enterprise AI as companies increasingly deploy a mix of open and closed models. The transaction is subject to regulatory approval and other customary conditions and is expected to close in Palo Alto Networks’ fiscal third quarter of 2027.
Post Image
Palo Alto Networks Jumps 8% Premarket as Q1 Growth Accelerates and FY27 Guidance Is Raised

Palo Alto Networks (NASDAQ: PANW) shares jumped 8% in premarket trading after the cybersecurity company reported strong fiscal first-quarter growth and materially raised its full-year outlook.

Revenue rose 39% year over year to $3.44 billion, while Next-Generation Security ARR surged 66% to $9.73 billion. Remaining performance obligations increased 35% to $21.0 billion, and non-GAAP operating income climbed to $1.1 billion from $746 million. Non-GAAP EPS rose to $1.05 from $0.93.

Cash generation was also strong, with adjusted free cash flow reaching $1.9 billion and a 56.2% margin. Palo Alto also announced plans to acquire Applied Compute, a platform focused on post-training and inference for open-weight AI models, extending its strategy around secure enterprise AI.

The 8% premarket rally appears to reflect the combination of rapid NGS ARR growth, strong cash flow and a substantial guidance increase. Palo Alto now expects fiscal 2027 revenue of $14.52-$14.57 billion, NGS ARR of $11.48-$11.53 billion and non-GAAP EPS of $4.26-$4.30, reinforcing expectations that cybersecurity demand remains resilient as AI-related threats and enterprise adoption accelerate.
Post Image
Palo Alto Networks Urges Shareholders to Reject Tutanota Mini-Tender Offer

Palo Alto Networks (NASDAQ: PANW) advised shareholders to reject an unsolicited mini-tender offer from Tutanota LLC seeking to purchase up to 250,000 shares of the cybersecurity company at $450 per share in cash.

The offer represents only about 0.03% of Palo Alto Networks’ outstanding common stock. The company said it does not endorse the offer and has no affiliation with Tutanota or the related tender documents.

A key concern is the offer’s pricing condition. Tutanota’s proposal requires Palo Alto Networks shares to close above $450 on the final trading day before expiration. Unless that condition is waived, shareholders accepting the offer would therefore receive a price below the prevailing market value.

Palo Alto Networks also noted that Tutanota can extend the offer for additional periods ranging from 45 to 180 days, potentially delaying payment. The offer is currently scheduled to expire at 5:00 p.m. ET on November 2, 2026, unless extended.

Because the offer seeks less than 5% of Palo Alto Networks’ outstanding shares, it is not subject to many of the disclosure and procedural protections that apply to larger tender offers under SEC rules. The SEC has previously warned investors that some mini-tender offers are structured below market prices and can catch shareholders who fail to compare the offer with current trading prices.

The announcement is primarily an investor-protection notice rather than a fundamental business development. Palo Alto Networks is encouraging shareholders to check current market quotations, consult their broker or financial adviser, and exercise caution before participating in the offer.
Post Image
Palo Alto Networks Stock Rises 5% as BTIG Raises Price Target and AI Security Momentum Builds

Palo Alto Networks shares rose 5% to $393.36 after BTIG Research raised its price target to $425 from $404 while maintaining a Buy rating.

The positive analyst action comes alongside growing investor interest in Palo Alto’s role in AI security. GuruFocus reported that the company joined NVIDIA’s AI agent safety initiative, which includes more than 100 organizations working on technologies designed to keep autonomous AI agents within defined operating limits.

Palo Alto is also building out its own AI security capabilities. Its Unit 42 offering uses models from OpenAI, Anthropic and others to continuously probe customer environments for vulnerabilities, while NVIDIA’s OpenShell and Sentry focus more on controlling and monitoring what AI agents can do at runtime (GuruFocus).

Broader probable reasons behind the stock’s strength include rising enterprise demand for AI security, stronger spending on cloud and network protection, and expectations that agentic AI will create new security requirements around identity, permissions, runtime controls and threat detection.

The 5% gain suggests the higher BTIG target and Palo Alto’s expanding presence in AI security are reinforcing confidence in the company’s long-term growth opportunity.
Post Image
Palo Alto Networks Launches AI-Powered Continuous Offensive Security Service With OpenAI and Anthropic Models

Palo Alto Networks launched Unit 42 Continuous Frontier AI Defense, a new agentic offensive security service that uses advanced models including OpenAI’s GPT-5.6-Cyber and Anthropic’s Claude Mythos 5 to continuously identify, validate and help remediate enterprise security exposures.

The service is designed to move beyond point-in-time assessments by continuously testing an organization’s environment as it changes. It combines a multi-model AI harness with Unit 42 threat intelligence and offensive security expertise to identify attack paths across web applications, APIs, cloud infrastructure, source-code repositories and network assets.

Palo Alto Networks said the system can also provide prioritized remediation guidance, code-level fixes and virtual patch recommendations. The company developed the approach over six months of internal testing and more than 100 customer engagements, supported by a $17 million R&D investment.

According to Palo Alto Networks, its Frontier AI Exposure Analysis identified exposures in 100% of assessed customers, with 37% of those exposures rated high or critical. The company also said many vulnerabilities in third-party applications had no known CVE, highlighting the potential value of continuous AI-driven testing.

Continuous Frontier AI Defense is available worldwide through annual subscriptions, with configurations varying according to the OpenAI, Anthropic and open-source models used.
Post Image
Palo Alto Networks Stock in Focus as Citi Downgrades Rating to Neutral

Palo Alto Networks (NASDAQ: PANW) received a more cautious analyst assessment after Citigroup downgraded the cybersecurity company from *Buy to Neutral*.

The downgrade comes with Palo Alto Networks trading at a premium valuation following strong investor enthusiasm around cybersecurity and artificial intelligence. While the company remains one of the leading players in enterprise cybersecurity, a Neutral rating can reflect a view that much of the expected growth and competitive strength is already incorporated into the share price.

Palo Alto Networks has built a broad security platform spanning network security, cloud security and security operations, positioning it strongly as enterprises consolidate cybersecurity spending around fewer strategic vendors. Its expanding use of AI across security products also provides exposure to continued growth in AI-driven threat detection and automation.

Citi’s move from Buy to Neutral therefore represents a moderation of its previous bullish stance rather than an outright bearish call, with valuation and the balance between future growth expectations and the current share price likely to remain important considerations for PANW investors.
Palo Alto Networks Stock Slips 1% Despite Strong Q4 as GAAP Loss and Slower FY2027 Growth Weigh

Palo Alto Networks (NASDAQ: PANW) shares fell about 1% in premarket trading Wednesday despite reporting strong fiscal fourth-quarter results, as investors weighed rapid cybersecurity growth against a GAAP loss and a significant expected deceleration in Next-Generation Security ARR growth.

Fourth-quarter revenue jumped 34% year over year to $3.41 billion, while Next-Generation Security ARR surged 63% to $9.10 billion. The company added nearly $1 billion of net new NGS ARR during the quarter, and remaining performance obligations increased 34% to $21.2 billion.

Profitability was more mixed. Non-GAAP operating income rose to $1.0 billion from $768 million a year earlier, while adjusted EPS increased to $1.02 from $0.95. However, Palo Alto Networks recorded a GAAP net loss of $282 million, or $0.35 per share, compared with net income of $254 million a year earlier. GAAP operating income also dropped to $172 million from $497 million.

Cash generation remained strong, with quarterly adjusted free cash flow reaching $1.3 billion and the full-year adjusted free cash flow margin at 38.4%.

The modest negative stock reaction may primarily reflect expectations embedded in Palo Alto Networks’ valuation and its FY2027 outlook. The company forecasts FY2027 revenue of $14.10 billion to $14.20 billion, representing 23%–24% growth, while NGS ARR is expected to reach $11.075 billion to $11.175 billion, representing 22%–23% growth. That implies a sharp normalization from the 63% NGS ARR growth reported in Q4.

Still, the underlying cybersecurity business remains strong. Palo Alto Networks expects Q1 FY2027 revenue growth of 33%–34% and NGS ARR growth of 63%, while management continues to target $20 billion in NGS ARR by FY2030. The company also acquired AI-native platform Console, extending its Cortex business into agentic enterprise security.

The roughly 1% premarket decline therefore appears less like a reaction to weak results and more like investor caution over slowing forward growth, GAAP profitability and high expectations following Palo Alto Networks’ rapid expansion in AI-driven cybersecurity.
Palo Alto Networks Launches Frontier AI Critical Defense Program to Counter AI-Driven Cyber Threats

Palo Alto Networks (NASDAQ: PANW) has launched its Frontier AI Critical Defense Program, bringing together major technology and infrastructure organizations to protect critical systems against vulnerabilities increasingly being discovered and potentially exploited using artificial intelligence.

The program includes collaborations with AI leaders OpenAI and Anthropic, alongside IBM, Red Hat and Microsoft. It also involves operational technology companies including Siemens, Mitsubishi and Axis Communications, as well as healthcare, energy, open-source and cybersecurity organizations.

AI Is Accelerating Vulnerability Discovery

Palo Alto Networks said it recently used Frontier AI models to identify more than 14,000 previously unknown vulnerabilities in open-source software. The company warned that similar technology could allow attackers to automate vulnerability discovery and dramatically shorten the time between finding and exploiting security weaknesses.

This presents a particular problem for critical infrastructure operators, where conventional software patches often require extensive safety testing and cannot be deployed immediately.

Palo Alto Networks aims to address this gap through "virtual patching." Its Frontier Virtual Patching technology can provide network-level protection against newly identified vulnerabilities before conventional software patches are developed, tested and installed.

The initiative expands Palo Alto Networks' position in AI-driven cybersecurity as both attackers and defenders increasingly use advanced AI models. By combining AI-based vulnerability discovery with network-level defenses and threat intelligence, the company is seeking to move cybersecurity from reactive patching toward proactive protection against emerging threats.
Palo Alto Networks (PANW) Stock Rises After Wells Fargo and BNP Paribas Raise Price Targets

Palo Alto Networks (NASDAQ: PANW) shares gained about 4.4% on Wednesday after receiving fresh bullish analyst support, with both Wells Fargo and BNP Paribas Exane raising their price targets while maintaining positive ratings on the cybersecurity leader.

The analyst actions reinforce Wall Street's confidence in Palo Alto Networks' long-term growth prospects as enterprises continue increasing investments in cybersecurity and AI-powered security platforms.

# Analysts See Further Upside

Wells Fargo raised its price target to $420 from $325 while reiterating its Overweight rating, reflecting greater confidence in the company's earnings growth and expanding platform strategy.

BNP Paribas also increased its price target to $380 from $330 while maintaining its Outperform rating, citing continued strength in the company's cybersecurity offerings and long-term market opportunity.

# Cybersecurity Demand Remains Strong

Palo Alto Networks continues to benefit from growing enterprise demand for integrated cybersecurity solutions as organizations consolidate vendors and strengthen defenses against increasingly sophisticated cyber threats.

The company's expanding AI-powered security capabilities and platform-based approach have helped drive customer adoption across network security, cloud security, and security operations.

# Why PANW Stock Is Rising Today

Investors welcomed several positive developments:

* Wells Fargo raised its price target to $420 from $325 and maintained an Overweight rating.
* BNP Paribas Exane increased its target to $380 from $330 and reiterated its Outperform rating.
* Wall Street continues to see strong long-term demand for enterprise cybersecurity solutions.
* AI-driven security products remain an important growth catalyst for the company.

The multiple price target increases reinforced investor confidence in Palo Alto Networks' growth strategy, helping lift the stock more than 4% during Wednesday's session.
Palo Alto Networks Stock Surges 8% as Arete Research Raises Price Target

Palo Alto Networks (NASDAQ: PANW) shares jumped more than 8% on Monday after Arete Research significantly increased its price target on the cybersecurity leader, reflecting growing confidence in the company's long-term growth outlook.

The firm maintained its Buy rating while raising its price target to $433 from $185, signaling a much more optimistic valuation as demand for enterprise cybersecurity solutions continues to strengthen.

The upgrade comes as organizations worldwide increase spending on cloud security, artificial intelligence-driven threat detection, and network protection amid a rapidly evolving cyber threat landscape. Palo Alto Networks remains one of the industry's leading providers, with investors expecting continued growth from its expanding platform strategy and subscription-based security offerings.

The stock also benefited from a broader rally in technology shares, as easing geopolitical tensions between the United States and Iran improved overall market sentiment and encouraged investors to rotate back into high-growth sectors.

At the time of writing, Palo Alto Networks shares were trading around $329, up approximately 8.4% during Monday's session, making the stock one of the strongest performers in the technology sector.
Video Thumbnail
11-19-26The Investor
Video Thumbnail
11-13-26The Investor
Video Thumbnail
09-18-26European Investor
Video Thumbnail
09-14-26WS Investor
Video Thumbnail
09-08-26The Investor

NYSE:BBWI

Bath & Body Works Rises 2.6% as Q3 Beats Guidance and Full-Year Sales Outlook Improves

Bath & Body Works (NYSE: BBWI) shares rose 2.6% after the retailer reported third-quarter sales and adjusted earnings above its guidance and raised its full-year sales outlook.

Third-quarter net sales declined 1.0% to $1.58 billion, while adjusted EPS came in at $0.26. Adjusted operating income was $121 million, compared with $153 million a year earlier, showing that profitability remains under pressure even as sales trends improve.

Management highlighted continued progress in digital, product innovation and expanded distribution through Ulta and Amazon. The company also authorized a new $500 million share repurchase program, adding support to the shareholder-return story.

The 2.6% gain appears to reflect the better-than-guided quarter, improved sales outlook and new buyback authorization. Bath & Body Works now expects full-year sales to decline 3.4%-2.1%, an improvement from its prior view, while maintaining adjusted EPS guidance of $2.60-$2.80. However, the company still expects fourth-quarter sales to fall 5.5%-2.0%, indicating that the consumer backdrop remains challenging.
Bath & Body Works Rises 3.6% as Q2 Beats Guidance and Turnaround Shows Early Progress

Bath & Body Works (NYSE: BBWI) shares rose about 3.6% after the retailer reported fiscal second-quarter 2026 sales and earnings above its guidance and raised its full-year earnings outlook. The positive reaction comes despite continued sales pressure, suggesting investors are focusing on early signs that the company's turnaround strategy is beginning to gain traction.

Q2 Results Beat Expectations

Second-quarter net sales were $1.51 billion, down 2.3% year over year. While revenue remained under pressure, management said the result exceeded its guidance.

Adjusted EPS reached $0.62, compared with $0.37 a year earlier, while adjusted operating income increased to $225 million from $172 million.

However, the headline earnings improvement was heavily influenced by approximately $80 million of tariff refunds. Excluding that benefit, adjusted EPS would have been $0.31.

That distinction is important: the quarter was better than management expected, but the reported year-over-year earnings growth substantially overstates the improvement in the underlying business.

Turnaround Signals Support the Stock

The more encouraging development may be operational rather than purely financial.

Bath & Body Works reported its first quarter of direct net sales growth since 2021, which management attributed partly to improvements in its digital shopping experience. The company also cited sequential improvement in Body Care, stronger average unit retail on new product innovation and continued momentum through marketplace partnerships.

CEO Daniel Heaf said these developments provide early evidence that the company's "Consumer First Formula" strategy is working, although he acknowledged that underlying business trends remain pressured.

For investors, evidence that digital sales and key product categories are stabilizing could be particularly important after an extended period of weak growth.

Full-Year EPS Guidance Raised, But Sales Still Expected to Fall

Bath & Body Works raised fiscal 2026 GAAP EPS guidance to $3.13-$3.33 and adjusted EPS guidance to $2.60-$2.80. The company also expects approximately $650 million of free cash flow.

Sales guidance was narrowed to a decline of 2.5%-4%, indicating that management still expects revenue contraction for the year.

The near-term outlook also remains challenging. For Q3, sales are expected to decline 2.5%-5%, while adjusted EPS of $0.07-$0.12 would be substantially below $0.35 in the year-ago quarter.

The 3.6% rise in BBWI therefore appears to reflect a cautiously positive reaction rather than a clear return to growth. Q2 exceeded guidance, digital sales improved and management raised its earnings outlook, providing evidence that the transformation is making progress. Still, declining sales, weak Q3 earnings guidance and the large contribution from tariff refunds show that the underlying recovery remains at an early stage.
BBWI fell 12% today after Bath & Body Works reported first-quarter 2026 earnings that exceeded guidance but reinforced investor concerns about slowing sales growth, weak forward outlooks and ongoing uncertainty surrounding the retailer’s turnaround strategy.

The company posted first-quarter net sales of $1.38 billion, down 3% year over year, while reaffirming its full-year forecast for revenue to decline between 4.5% and 2.5%. Management also projected second-quarter sales to fall another 3% to 5%, signaling that demand pressures are expected to persist through much of 2026.

Although reported earnings per diluted share rose to $0.90 from $0.49 a year earlier, much of the improvement came from one-time items, including an $88 million pre-tax litigation settlement gain and a $62 million tax benefit. Excluding special items, adjusted EPS came in at just $0.32, reflecting ongoing pressure on the core business.

CEO Daniel Heaf acknowledged that while results exceeded guidance, performance still remains “below the standard our brand is capable of delivering.” The company said its “Consumer First Formula” turnaround plan is beginning to generate early positive signs through investments in hero product categories, brand modernization and customer engagement initiatives, but management made clear that meaningful improvement is expected to build gradually into 2027 rather than immediately.

Investors also appeared unsettled by the sudden departure of Chief Financial Officer Eva Boratto, who will step down in June. The company announced an interim CFO appointment while conducting a broader executive search, creating additional uncertainty at a time when Bath & Body Works is already navigating slowing sales and shifting consumer demand trends.

The market reaction suggests investors were hoping for stronger evidence of stabilization and a more optimistic near-term outlook. While Bath & Body Works maintained full-year earnings guidance and continues to generate solid cash flow, the retailer still faces a difficult environment marked by cautious consumer spending, promotional competition and pressure on discretionary retail categories.

The sharp selloff indicates investors remain skeptical that the company’s turnaround efforts will produce a meaningful acceleration in growth anytime soon, despite management’s confidence in the longer-term recovery strategy.
Bath & Body Works Appoints Daniel Heaf as CEO; Reports Strong Q1 2025 Results

Bath & Body Works, Inc. (NYSE: BBWI) announced the appointment of Daniel Heaf as Chief Executive Officer, effective immediately. Heaf, a seasoned leader with prior senior roles at Nike and Burberry, will also join the Board of Directors following the 2025 Annual Meeting. He replaces Gina Boswell, who has stepped down.

Heaf brings extensive experience in consumer and retail transformation. At Nike, he previously led the direct-to-consumer business to more than double in size and most recently served as Chief Strategy and Transformation Officer.

First Quarter 2025 Preliminary Results:
• Net Sales: $1.424 billion (up 3% year-over-year), meeting the high end of guidance.
• Earnings Per Share: $0.49, exceeding the high end of guidance.
• Full-Year Outlook Maintained: Sales growth of 1% to 3% and EPS of $3.25 to $3.60.
The company will hold its earnings call on May 29, 2025, at 8:30 a.m. ET.

Chair Sarah Nash praised Heaf as a bold, consumer-first leader with a clear vision to evolve the brand. Heaf emphasized Bath & Body Works’ potential to grow into a global home fragrance and beauty leader, citing the company’s strong foundation of brand loyalty and retail footprint.
Bath & Body Works, Inc. has announced that its Chief Executive Officer, Gina Boswell, will take a temporary leave of absence to undergo scheduled surgery. The absence is expected to last several weeks.
Bath & Body Works, Inc. has filed a Form 8-K with the SEC, reaffirming its financial guidance for the first quarter and full year of fiscal 2025. During its participation in the Bank of America Consumer & Retail Conference – Fireside Chat on March 11, 2025, the company reiterated its previously announced projections.

For the first quarter of 2025, the company expects net sales growth between 1% and 3% and earnings per diluted share in the range of $0.36 to $0.43. For the full fiscal year 2025, net sales growth is projected to be between 1% and 3%, with earnings per diluted share estimated between $3.25 and $3.60.

The company made this announcement in connection with its investor presentation, and the audio webcast of the event is available on the company's Investor Relations website. The information was furnished under Regulation FD and is not considered filed under the Exchange Act.
Bath & Body Works reported its fourth-quarter and full-year 2024 results, exceeding earnings expectations and providing 2025 guidance.

The company recorded fourth-quarter net sales of $2.8 billion and earnings per diluted share of $2.09, surpassing projections. Strong traffic and conversion rates contributed to performance, despite a 4.3% decline in sales due to a shifted fiscal calendar that included an extra week in 2023. Net income for the quarter was $453 million, down from $579 million in the prior year.

For the full year, net sales declined 1.6% to $7.3 billion, reflecting the impact of the 53rd week in fiscal 2023. Earnings per diluted share were $3.61, compared to $3.84 in 2023. The company repurchased 10.4 million shares for $400 million and exited the year with a debt leverage ratio of 2.5x.

Looking ahead to 2025, Bath & Body Works expects net sales growth of 1% to 3% and earnings per diluted share between $3.25 and $3.60. The first quarter is projected to see similar sales growth, with earnings per diluted share between $0.36 and $0.43. The company also authorized a new $500 million share repurchase program.

CEO Gina Boswell highlighted the company’s success in product innovation, marketing, and international expansion, positioning it for continued growth despite broader retail sector challenges.
Video Thumbnail
11-19-26The Investor

NYSE:WSM

Williams-Sonoma Falls 7.2% Premarket as Reiterated Outlook Disappoints Despite Strong Q3

Williams-Sonoma (NYSE: WSM) shares fell 7.2% in premarket trading despite reporting solid third-quarter sales growth, margin expansion and double-digit adjusted EPS growth.

Comparable brand revenue increased 5.1%, while net revenue rose 5.8%. Non-GAAP operating margin improved 40 basis points to 17.4%, and adjusted diluted EPS increased 11.7% to $2.19. Every brand and channel posted positive comparable growth.

Underlying profitability remained strong, but some of the headline margin improvement came from tariff refunds. GAAP gross margin expanded 150 basis points, including a 140-basis-point benefit from IEEPA tariff refunds, while the non-GAAP gross margin increased only 10 basis points. Inventory also rose 7.3%, faster than revenue.

The 7.2% premarket decline appears to reflect disappointment that Williams-Sonoma merely reiterated its full-year outlook despite the strong quarter. Investors may also be focusing on elevated inventory, higher supply-chain costs and the limited underlying gross-margin expansion once tariff benefits are excluded. The company continues to expect fiscal 2026 revenue growth of 4.7%-7.2%, comparable growth of 4.0%-6.5% and a non-GAAP operating margin of 17.8%-18.2%.
Williams-Sonoma Stock Falls 2% Despite Strong Q2 Results and Raised 2026 Outlook

Williams-Sonoma (NYSE: WSM) shares fell about 2% on Wednesday even after the home furnishings retailer reported strong second-quarter fiscal 2026 results and raised its full-year outlook.

The decline appears to reflect investor concerns over underlying margin pressure and the quality of the earnings beat, as a significant portion of the company's GAAP profit improvement came from one-time tariff refunds.

Sales Growth Remains Strong

Williams-Sonoma reported comparable brand revenue growth of 6.2%, while total revenue increased 6.7% year over year. Management said every brand delivered growth during the quarter and that the company continued to gain market share despite a challenging housing environment.

Non-GAAP diluted EPS rose 5% to $2.10, while non-GAAP operating income reached $338 million. The company maintained $1.0 billion in cash and generated $696 million in operating cash flow.

However, underlying profitability showed some pressure. Non-GAAP gross margin declined 160 basis points year over year to 45.5%, primarily because merchandise margin fell 230 basis points due to tariff costs. Non-GAAP operating margin declined 60 basis points to 17.3%.

Tariff Refunds Boost GAAP Earnings

The headline GAAP numbers were considerably stronger, with operating margin reaching 22.9% and diluted EPS jumping 42% to $2.84.

But these figures benefited substantially from tariff-related items. Williams-Sonoma recognized $167.8 million in reductions to cost of goods sold from refunds of previously paid IEEPA tariffs, partially offset by vendor reimbursements and a $10 million employee recognition expense.

The company therefore excluded these items from its non-GAAP results, making the adjusted figures a better indication of underlying operating performance.

Williams-Sonoma Raises 2026 Guidance

Williams-Sonoma nevertheless increased its full-year expectations. The company now forecasts fiscal 2026 net revenue growth of 4.7% to 7.2%, comparable revenue growth of 4.0% to 6.5%, and a non-GAAP operating margin of 17.8% to 18.2%.

The outlook assumes existing tariffs remain in place and oil prices stay elevated for the rest of the year.

The roughly 2% decline in WSM shares therefore appears less about weak demand and more about investors looking beneath the headline earnings numbers. Strong sales growth and higher guidance were positives, but declining underlying merchandise margins and continued tariff pressure may be limiting enthusiasm after the report.
Williams-Sonoma Stock Rises in Premarket After Piper Sandler Initiates Coverage With Overweight Rating

Williams-Sonoma (NYSE: WSM) shares gained 2.2% in premarket trading on Monday after Piper Sandler initiated coverage of the home furnishings retailer with an Overweight rating.

The analyst initiation reflects confidence in Williams-Sonoma's ability to sustain earnings growth despite a challenging consumer spending environment. The company has continued to benefit from its portfolio of premium brands, including Pottery Barn, West Elm, and Williams Sonoma, as well as its strong e-commerce platform and disciplined inventory management.

Piper Sandler's bullish stance comes as investors increasingly favor retailers with resilient margins, healthy cash generation, and loyal customer bases. Williams-Sonoma has consistently outperformed many peers through effective pricing strategies, operational efficiency, and a capital-light business model that has supported profitability even as discretionary spending has moderated.

The positive analyst action also follows improving sentiment toward the retail sector, supported by expectations that lower U.S. interest rates could help boost housing activity and consumer demand for home-related products over time.

Looking ahead, investors will focus on Williams-Sonoma's upcoming earnings report for updates on comparable sales, consumer demand trends, and margin performance. Any signs of a recovery in the housing market or discretionary spending could provide additional support for the stock in the coming quarters.
Williams-Sonoma Rises 2% as Consistent Execution and Margin Resilience Reassure Investors

Williams-Sonoma edged up 2% after the premium home furnishings retailer delivered a first quarter that demonstrated the kind of steady, reliable performance that has become its trademark — every brand positive, margins holding firm and full-year guidance reiterated with confidence.

Total comparable brand revenue grew 4.8% in Q1, with every brand in the portfolio delivering positive comps. Operating income came in at $292 million with an operating margin of 16.2%, down just 60 basis points from a year ago. Diluted EPS grew 4.3% to $1.93. The company generated $156 million in operating cash flow and returned $373 million to shareholders through $288 million in buybacks and $85 million in dividends, all while maintaining a liquidity position of $652 million in cash.

The margin story deserves careful reading in the context of the current tariff environment. Gross margin of 44.0% declined 30 basis points year over year, reflecting lower merchandise margins of 100 basis points weighed down by tariff costs, partially offset by 50 basis points of supply chain efficiencies and 20 basis points of occupancy leverage. Merchandise inventories rose 9.0% to $1.46 billion, explicitly including approximately $60 million in incremental tariff costs — a figure that illustrates the real cost pressure the business is absorbing while still delivering positive comparable sales growth.

CEO Laura Alber's commentary was notably confident, pointing to compounding results year after year despite housing market cyclicality and macroeconomic headwinds. Full-year guidance was reiterated at comparable revenue growth of 2.0% to 6.0% and operating margin of 17.5% to 18.1% — a range that explicitly assumes elevated oil prices, no tariff refunds and all current tariff rates remaining in place for the full year.

The 2% gain reflects a market that found reassurance in a company that is not hiding from the tariff reality but rather building it into its assumptions and still delivering solid results. In a week where Walmart fell 7% and Target dropped 6.5% partly on margin concerns, Williams-Sonoma's ability to hold margin while absorbing tariff costs and grow comps across every brand was a genuinely differentiated message.

Three Brand Name Companies Outside Of Tech That Are On The Move

Last week’s push to new highs in the market continued...

(articles.stockcharts.com)
Williams-Sonoma Reports Strong Q1 2025 Results, Reaffirms Full-Year Outlook Despite Tariff Headwinds

Williams-Sonoma, Inc. (NYSE: WSM) announced solid first quarter fiscal 2025 results, with strong profitability and better-than-expected revenue growth, while reaffirming its full-year guidance.

Q1 2025 Highlights:
• Comparable brand revenue growth: +3.4%
• Net revenues: $1.73 billion, up 4.2% year-over-year
• Operating margin: 16.8%
• Diluted EPS: $1.85 (up 8.8% excluding a prior year freight adjustment)
• SG&A expenses: $475 million, or 27.5% of revenues (down 130bps from last year)
• Gross margin: 44.3% (adjusted -60bps YOY after excluding a prior year adjustment)
• Net income: $231 million
• Merchandise inventories: Up 10.3% to $1.3 billion, strategically pulled forward due to tariff concerns
• Cash position: $1.05 billion, despite $165 million returned to shareholders through buybacks and dividends

Brand Performance (Comparable Revenue Growth):
• Williams Sonoma: +7.3%
• Pottery Barn Kids and Teen: +3.8%
• Pottery Barn: +2.0%
• West Elm: +0.2%
• Total: +3.4%
Outlook:
• Full-year FY25 guidance reaffirmed:
o Net revenue range: -1.5% to +1.5%
o Comparable sales: flat to +3.0%
o Operating margin: 17.4% to 17.8%
• Guidance incorporates significant tariff impacts (30% on China, 25% on Mexico/Canada/steel/aluminum, 10% global reciprocal tariffs)
• Long-term goals remain unchanged: mid-to-high single-digit annual revenue growth and operating margins in the mid-to-high teens

Additional Notes:
• Q1 results include a retrospective adjustment from FY24 related to over-recognized freight expenses totaling $49 million, which impacted prior year comparables.
• A 2-for-1 stock split took effect on July 9, 2024; all share data reflects the split.
• The company ended Q1 with 508 stores, a net reduction of four locations during the quarter.

CEO Laura Alber cited strong performance across all brands and reaffirmed confidence in the company’s ability to adapt amid ongoing macroeconomic uncertainty.
Williams-Sonoma, Inc. reported strong fourth-quarter and fiscal year 2024 results, surpassing expectations in key financial metrics. The company achieved a 3.1% increase in comparable brand revenue for Q4, along with a record operating margin of 21.5% and diluted EPS of $3.28. For the full fiscal year, comparable brand revenue declined by 1.6%, but the company still delivered a record annual operating margin of 17.9% and full-year diluted EPS of $8.50.

CEO Laura Alber highlighted the company's focus on operational efficiency, strategic product launches, and robust demand in retail and online furniture sales. She expressed confidence in the company's strategies for 2025, emphasizing a return to growth, enhanced customer service, and strong earnings performance.

Q4 gross margin increased to 47.3%, benefiting from occupancy leverage (+80 bps), higher merchandise margins (+40 bps), and supply chain efficiencies (+10 bps). Operating income reached $530 million, up 140 basis points year-over-year, while SG&A expenses increased by 7.6%, primarily due to higher performance-based compensation and advertising. The additional week in Q4 2024 contributed approximately 5.1% to revenue growth and 60 basis points to operating margin.

For the full fiscal year, the company achieved an operating income of $1.43 billion and an operating margin of 18.6%, or 17.9% excluding a $49 million out-of-period freight adjustment recorded in Q1. The company maintained strong liquidity with $1.2 billion in cash and generated $1.4 billion in operating cash flow. It returned $1.1 billion to shareholders through $807 million in stock repurchases and $280 million in dividends. The board approved a 16% increase in the quarterly dividend, raising it to $0.66 per share.

Looking ahead to fiscal 2025, Williams-Sonoma expects net revenue growth between -1.5% and +1.5% due to the impact of an extra week in 2024. On a comparable 52-week basis, the company projects comps between flat and +3.0% and an operating margin between 17.4% and 17.8%. Over the long term, it continues to target mid-to-high single-digit annual net revenue growth with an operating margin in the mid-to-high teens.

During Q1 2024, the company corrected a historical over-accrual of freight expenses, resulting in a one-time adjustment of $49 million that benefited gross margin. In Q2, it also completed a 2-for-1 stock split.

Segment-wise, Q4 revenue growth was led by Williams Sonoma (+5.7%), West Elm (+4.2%), and Pottery Barn Kids and Teen (+3.5%), while Pottery Barn saw a slight decline (-0.5%). For the full year, Pottery Barn (-6.2%) and West Elm (-2.0%) reported declines, while Williams Sonoma (+2.4%) and Pottery Barn Kids and Teen (+3.0%) posted gains.

The company continues to focus on innovation, operational efficiencies, and strategic investments to drive long-term profitability while maintaining a disciplined approach to cost management and shareholder returns.
Video Thumbnail
11-19-26The Investor
Video Thumbnail
08-26-26The Investor
Video Thumbnail
06-03-26WS Investor
Video Thumbnail
03-13-25The Investor

S&P 500

Infleqtion Rises 1.9% After Hours on Record Revenue and 30-Logical-Qubit Milestone

Infleqtion (NYSE: INFQ) shares rose 1.9% in after-hours trading after the quantum technology company reported record third-quarter revenue and maintained its full-year outlook.

Revenue increased 25% year over year to $9.1 million, while nine-month revenue rose 57% to $32.6 million. Infleqtion reiterated its 2026 revenue guidance of at least $45.1 million.

The company also achieved its 2026 target of demonstrating 30 entangled logical qubits in a single computation and ended the quarter with $560 million in cash and securities and no debt. However, its GAAP operating loss widened to $34.5 million from $6.7 million a year earlier.

The after-hours gain appears to reflect investor enthusiasm around the company’s quantum computing milestone, growing backlog and customer activity, despite continued heavy operating losses.
Post Image
U.S. Stocks Fall as Nasdaq Drops 1.5% and S&P 500 Slides Nearly 1%

U.S. stocks traded lower, with technology shares leading the decline as the Nasdaq Composite fell 1.54% to 24,974.47.

The S&P 500 dropped 0.97% to 7,518.86, while the Dow Jones Industrial Average declined 0.45% to 52,059.91.

The sharper Nasdaq decline points to heavier selling pressure in technology and other growth-oriented stocks, while the Dow’s smaller loss suggests relative resilience among large-cap industrial and value names.

The broad weakness comes as investors reassess the outlook for interest rates, Nvidia scandal and inflation following fresh U.S. economic data, contributing to a more cautious tone across equity markets.
Post Image
S&P 500 Edges Higher as Energy and Communication Services Lead Gains

The S&P 500 was modestly higher in midday trading, rising about 0.17% to 7,632.36 as strength in energy and communication services offset weakness in technology and materials.

Energy was the strongest-performing sector, gaining 1.83%, followed by communication services at 1.00%. Utilities rose 0.64%, consumer staples gained 0.49%, consumer discretionary advanced 0.38% and health care added 0.36%.

The broader market initially traded lower after the open before rebounding sharply during the late morning session. The S&P 500 briefly approached the 7,650 level before giving back part of its gains and stabilizing near 7,630 around midday.

Defensive and cyclical sectors generally outperformed technology. Real estate slipped 0.02%, financials fell 0.04% and industrials declined 0.06%. Information technology was down 0.32%, while materials was the weakest sector with a 0.49% decline.

The mixed sector performance suggests investors were rotating away from some technology and materials names while maintaining exposure to energy, communication services and defensive sectors.

With the S&P 500 holding slightly positive despite weakness in several major sectors, the session reflects a relatively balanced market rather than a broad-based risk-on move.
Post Image
U.S. CPI Rises More Than Expected in October as Core Inflation Holds at 0.3%

U.S. consumer prices rose 0.4% month over month in October, above the 0.3% forecast but slowing from September’s 0.6% increase.

Core CPI, which excludes food and energy, increased 0.3%, also exceeding the 0.2% forecast and matching the previous month’s pace.

Separately, ADP’s weekly employment measure showed private payrolls increasing by 19,800, slightly above the previous reading of 19,500.

U.S. equities traded modestly lower following the data. The S&P 500 was down 0.19%, the Dow Jones Industrial Average fell 0.35%, and the Nasdaq declined 0.06%.

The hotter-than-expected headline and core CPI readings suggest underlying inflation pressures remain persistent, potentially reinforcing expectations that the Federal Reserve will remain cautious about further monetary-policy easing.
Post Image
U.S. Jobless Claims Fall to 189,000 as Tech Stocks Slide

U.S. initial jobless claims fell to 189,000, below the 197,000 forecast and down from 195,000 previously, pointing to continued resilience in the labor market.

Continuing jobless claims, however, increased to 1.718 million from 1.695 million, slightly above the 1.710 million forecast. The combination suggests layoffs remain low, while workers already unemployed may be taking somewhat longer to find new jobs.

U.S. equities traded mixed following the data. The Dow Jones Industrial Average rose about 0.54%, while the S&P 500 fell 0.32% and the Nasdaq declined 1.12%.

The stronger initial claims reading may reinforce expectations that the labor market remains relatively firm, potentially limiting the case for faster monetary easing. The heavier decline in the Nasdaq suggests rate-sensitive technology stocks were under greater pressure, while the Dow showed relative strength.
Post Image
U.S. Stock Futures Rally After Democratic Midterm Sweep as ADP Employment Matches Prior Month

U.S. stock futures moved sharply higher on Wednesday as investors digested the Democratic sweep of both chambers of Congress and a stronger-than-expected private-sector employment report.

Dow futures climbed about 2.1%, S&P 500 futures rose 1.1%, while Nasdaq futures gained 0.4%. The broader move followed confirmation that Democrats won control of both the House and Senate in the November 3 midterm elections, creating a divided government with Republican President Donald Trump.

Labor-market data also provided support. ADP reported that U.S. private payrolls increased by 86,000 in October, matching the previous month’s reading and exceeding the 67,000 forecast. The result points to continued hiring momentum, although employment growth remains relatively moderate.

The market reaction suggests investors are balancing two themes. The election outcome has increased expectations that large legislative changes may become more difficult, while the ADP report indicates the labor market has not weakened sharply. Together, those factors supported cyclical shares and helped push Dow futures substantially higher.

The Nasdaq’s smaller gain also reflects a more complicated post-election backdrop for technology stocks. Democratic victories have increased investor focus on possible tighter oversight of AI infrastructure and data-center development, particularly after election campaigns in several states highlighted concerns over energy use, utility costs and local opposition to new data centers.

Overall, the combination of greater political clarity and resilient employment data is supporting U.S. equities ahead of the opening bell. However, investors are likely to remain focused on how the new congressional balance may affect fiscal policy, AI regulation and future Federal Reserve decisions.
Post Image
U.S. Stocks Rise as Oil Plunges and ISM Manufacturing Beats Forecasts

U.S. stocks extended gains Monday as sharply lower oil prices eased inflation concerns and stronger-than-expected ISM manufacturing data supported confidence in the economy.

The Dow Jones rose 1.03% to 52,304.31, the Nasdaq gained 0.87% to 25,658.79, and the S&P 500 advanced 0.62% to 7,627.00.

Brent crude fell more than 6% to around $106.41 a barrel. The sharp decline in energy prices provides a favorable backdrop for equities by reducing concerns over fuel-driven inflation and potentially lowering costs for businesses and consumers.

Economic data also offered support. The ISM Manufacturing PMI increased to 55.5 in October, beating the 54.5 forecast and improving from 54.5 previously. The reading remained well above the 50 threshold, indicating continued expansion in U.S. manufacturing activity.

At the same time, the ISM Manufacturing Prices index eased to 75.2 from 77.9 and came in below the 77.2 forecast. Although input-price pressures remained elevated, the decline provided some reassurance on the inflation outlook. Manufacturing employment slipped slightly to 52.4 from 52.7 but remained in expansion territory.

Construction spending was the major weak point, falling 1.9% month over month in September compared with expectations for a 0.4% increase and a previous 2.0% gain.

Overall, the rise in U.S. indexes appears to reflect a combination of sharply lower oil prices, stronger manufacturing activity and some moderation in manufacturing price pressures. The weak construction spending figure limited the otherwise positive macro picture but was not enough to offset the broader improvement in investor sentiment.
Post Image
U.S. Stocks Trade Mixed as Wider Trade Deficit Offsets Inventory Growth

U.S. stocks were mixed after fresh economic data showed a wider-than-expected goods trade deficit alongside stronger retail inventory growth. The S&P 500 rose 0.15% and the Dow gained 0.27%, while the Nasdaq was nearly unchanged, down 0.01%.

The U.S. goods trade deficit widened to $134.90 billion in September, larger than the $130.40 billion consensus estimate and the previous $132.07 billion deficit. The deterioration suggests imports continued to outpace exports and could weigh on the trade component of third-quarter GDP calculations.

Retail inventories excluding autos increased 0.4% in September, accelerating from 0.1% previously. Higher inventories can provide some near-term support to GDP, although persistent inventory accumulation can become a negative signal if it reflects weaker-than-expected final demand.

Overall, the releases offered a mixed economic signal: stronger inventory accumulation was offset by a larger trade deficit, helping explain the relatively subdued reaction across major U.S. equity indexes.
Post Image
Wall Street Rises as Strong Consumer Confidence Offsets Mixed U.S. Economic Data

U.S. stocks moved higher Tuesday, with the Nasdaq gaining 1.19%, the S&P 500 rising 0.66% and the Dow Jones adding 0.14%, as investors digested a mixed batch of economic data.

Conference Board Consumer Confidence climbed to 91.7 in October, well above the 81.2 forecast and up from 84.2 previously. The stronger-than-expected reading pointed to improved household sentiment and provided the clearest positive signal from the day’s releases.

New home sales also came in better than expected at an annualized 676,000 in September, compared with the 651,000 forecast, although sales edged down from 680,000 previously.

Other indicators were softer. Building permits slipped to 1.398 million, slightly below the 1.400 million forecast and 1.403 million prior reading. Weekly ADP employment growth slowed to 16,800 from 18,500, suggesting some moderation in private-sector hiring.

Durable goods orders rose 1.8% in September, a sharp improvement from the prior 0.1% increase but slightly below the 2.0% consensus estimate.

Overall, the data presented a mixed economic picture, with stronger consumer confidence and housing demand offsetting softer employment and building activity. The stronger move in the Nasdaq suggests risk appetite remained relatively firm despite the uneven macro signals.
Wall Street Falls as Mixed Jobless Claims and Surging Oil Keep Rate and Inflation Concerns in Focus

U.S. stocks traded lower after the latest labor-market data sent a mixed signal while a sharp rise in crude oil added to inflation concerns.

Initial jobless claims fell to 194,000, better than the 200,000 consensus estimate and down from 200,000 previously. The reading suggests layoffs remain relatively contained and the labor market is still holding up.

Continuing jobless claims, however, rose to 1.728 million, above the 1.720 million forecast and up from 1.703 million previously. That points to some difficulty for unemployed workers in finding new jobs even as new layoffs remain low.

Equities were under pressure, with the S&P 500 down about 0.78%, the Dow Jones Industrial Average off 0.15%, and the Nasdaq falling roughly 1.42%. The heavier Nasdaq decline suggests continued pressure on rate-sensitive growth and technology stocks.

At the same time, Brent crude climbed about 2.4% to $111.48 per barrel. Higher oil prices can complicate the inflation outlook by increasing energy and transportation costs, potentially reinforcing concerns that the Federal Reserve may need to keep monetary policy restrictive for longer.

Overall, the combination of resilient initial claims and rising oil prices appears to be weighing on risk appetite, even as the increase in continuing claims points to some underlying softening in the labor market.
Video Thumbnail
11-19-26The Investor
Video Thumbnail
11-19-26The Investor
Video Thumbnail
11-17-26The Investor
Video Thumbnail
11-17-26The Investor
Video Thumbnail
11-10-26European Investor

NYSE:WMT

Post Image
Walmart Slips 1.6% Premarket Despite Q3 Growth and Raised FY27 Outlook

Walmart (NASDAQ: WMT) shares fell 1.6% in premarket trading despite reporting solid third-quarter growth and raising its fiscal 2027 outlook.

Revenue increased 5.2% year over year to $188.8 billion, or 4.5% in constant currency. Global eCommerce sales rose 17%, including 23% growth in Walmart U.S., while the global advertising business increased 25% and membership fee revenue grew 17%.

Profitability also improved, with gross margin up 28 basis points and operating income increasing 16.0%. Adjusted EPS came in at $0.65. Walmart also highlighted 37% growth in U.S. advertising and launched a new $120 annual bundle combining Walmart+ and Sam’s Club Plus.

The 1.6% premarket decline appears to reflect high investor expectations and some caution around inventory and balance-sheet trends despite the strong operating performance. Global inventory increased 8.1%, outpacing revenue growth, while Walmart also issued $6.5 billion of long-term debt. Those factors may have tempered enthusiasm even as the company raised its full-year outlook.
Walmart Stock Falls 9% Premarket Despite Revenue Growth as Earnings Disappoint

Walmart (NASDAQ: WMT) shares fell about 9% Thursday despite reporting solid second-quarter revenue growth and strong e-commerce performance, as investors focused on earnings that fell short of market expectations and continued tariff-related uncertainty.

Revenue Grows 5.9%, E-Commerce Jumps 23%

Second-quarter revenue increased 5.9% to $187.9 billion, or 5.1% in constant currency.

Global e-commerce sales jumped 23%, supported by store-fulfilled pickup and delivery and marketplace growth. Walmart's global advertising business increased 38%, while membership fee revenue grew 17%.

Operating income rose 28.8%, or 17.4% on an adjusted constant-currency basis, helped partly by tariff refunds. Adjusted EPS came in at $0.81.

Earnings and Tariff Concerns Pressure WMT

Despite strong top-line growth, the market reaction suggests investors were disappointed with profitability relative to expectations. Walmart's adjusted EPS of $0.81 was below Wall Street expectations, overshadowing the strong revenue performance.

Tariffs also remain an important issue. Walmart said operating income benefited from tariff refunds during the quarter, partially offset by price investments. The company plans to prioritize remaining tariff refunds toward further price investments, potentially limiting the benefit to future earnings.

Walmart reiterated its fiscal 2027 outlook and issued third-quarter guidance, but the combination of an earnings miss, elevated inventory and continued tariff-related margin uncertainty appears to be driving WMT's 9% decline.
Walmart Completes Vibe*co Acquisition to Expand Connected TV Advertising Business

Walmart announced it has completed its acquisition of Vibe*co, a self-service connected TV (CTV) advertising platform, strengthening Walmart Connect's commerce media business and expanding its presence in streaming television advertising.

The acquisition combines Vibe*co's self-service advertising platform with Walmart Connect's retail media capabilities, enabling advertisers to plan, purchase and measure streaming TV campaigns more easily. Walmart said the deal will make connected TV advertising more accessible for businesses of all sizes while helping brands better connect advertising campaigns with measurable shopping outcomes.

Vibe*co, founded in 2021, has developed a platform used by more than 10,000 advertisers to launch streaming TV campaigns across premium publishers through simplified campaign management, flexible budgets and AI-powered optimization.

Walmart said the acquisition will enhance Walmart Connect's ability to deliver closed-loop advertising solutions by integrating first-party customer insights with streaming, digital and in-store advertising channels. The company expects the transaction to create new opportunities for suppliers, marketplace sellers and brands to reach customers throughout the shopping journey while improving campaign measurement and effectiveness.

The acquisition reflects Walmart's continued investment in its rapidly growing advertising business as retailers increasingly expand beyond traditional retail operations into high-margin retail media and digital advertising services.
Walmart Gains 1% as Investors Favor Defensive Stocks Despite Analyst Downgrade

Walmart shares rose 1% on Friday, outperforming the broader market as investors sought safety in defensive sectors during a sharp selloff that pushed major technology indexes significantly lower.

The gain came even as Erste Group Bank downgraded the stock from Buy to Hold. While downgrades often pressure shares, the market appeared more focused on Walmart's defensive characteristics and resilient business model amid growing economic uncertainty.

As concerns about higher-for-longer interest rates weighed heavily on technology and growth stocks, investors rotated into companies with stable earnings, strong cash flow, and consistent consumer demand. Walmart is widely viewed as one of the largest beneficiaries of this type of market environment due to its dominant position in grocery retailing and its ability to attract consumers across income levels.

The retailer has also strengthened its competitive position through investments in e-commerce, delivery services, advertising, and membership offerings. These higher-margin businesses have helped diversify revenue streams and improve profitability beyond traditional retail operations.

Friday's positive performance suggests investors remain confident in Walmart's ability to navigate a potentially slower economic environment. Historically, the company has performed relatively well during periods of economic uncertainty as consumers increasingly prioritize value and essential purchases.

The divergence between the analyst downgrade and the stock's gain highlights the current market dynamic. While some analysts may see more limited upside after Walmart's strong performance over recent years, investors continue to view the company as a high-quality defensive holding capable of delivering steady growth and earnings stability even as broader market volatility increases.

With interest-rate expectations remaining elevated and economic uncertainty persisting, Walmart's combination of scale, pricing power, and essential consumer exposure continues to make it an attractive destination for investors seeking stability in an increasingly turbulent market environment.
Walmart Falls 7% Despite Solid Quarter as Guidance Disappoints Investors

Walmart dropped 7% after the world's largest retailer reported a broadly solid first quarter but issued second quarter guidance and reiterated full-year commentary that left investors wanting more, particularly against the backdrop of a macro environment where consumer staples companies are expected to demonstrate resilience.

Revenue for Q1 came in at $177.8 billion, up 7.3% year over year or 5.9% in constant currency — a healthy topline for a company of Walmart's scale. Global eCommerce sales grew 26%, led by store-fulfilled pickup and delivery and marketplace, continuing the digital transformation that has been central to Walmart's investment thesis. The global advertising business surged 37%, with Walmart US advertising up 36%, and membership fee revenue grew 17.4% globally — both high-margin revenue streams that point to the structural evolution of the business beyond traditional retail. Gross profit rate improved 6 basis points, led by Walmart US. Operating income grew 5.0%, or 5.1% on an adjusted constant currency basis. GAAP EPS was $0.67 and adjusted EPS was $0.66.

On the surface these are respectable numbers. The issue for investors lies in what comes next. The company reiterated its full-year fiscal 2027 outlook rather than raising it, and the Q2 guidance it issued apparently failed to clear the bar a market had set following strong results from TJX and other retailers this week. Inventory was up 8.9%, partly reflecting timing of receipts and strong grocery demand, but elevated inventory levels require monitoring in a demand environment that remains uncertain.

The 7% decline is steep for a company that delivered mid-single digit operating income growth and accelerating digital revenue. It reflects a market that had priced in a guidance raise following weeks of positive retail sentiment, and found instead a company that is performing well but choosing to hold its cards rather than signal acceleration. In the current environment, where every retailer faces tariff cost pressures and consumer spending uncertainty, a reiterated rather than raised outlook was read as a cautious message regardless of the underlying momentum.
Walmart reported continued growth momentum, with revenue increasing 5.1% in constant currency to $715.9 billion and profit rising 5.4% on an adjusted basis. The company’s global eCommerce sales surged 24% to $150.4 billion, supported by strong performance across marketplace, advertising, and membership segments.

Operating cash flow reached $41.6 billion, while Walmart returned $15.6 billion to shareholders through dividends and share repurchases. The company also highlighted rapid expansion in advertising revenue and ongoing investments in technology, including AI-driven tools to enhance customer experience and operational efficiency.

Management emphasized that the integration of physical stores and digital platforms, along with supply chain innovation, continues to strengthen Walmart’s business model and support future growth.

Source: Walmart
Walmart reported continued growth momentum, with revenue increasing 5.1% in constant currency to $715.9 billion and profit rising 5.4% on an adjusted basis. The company’s global eCommerce sales surged 24% to $150.4 billion, supported by strong performance across marketplace, advertising, and membership segments.

Operating cash flow reached $41.6 billion, while Walmart returned $15.6 billion to shareholders through dividends and share repurchases. The company also highlighted rapid expansion in advertising revenue and ongoing investments in technology, including AI-driven tools to enhance customer experience and operational efficiency.

Management emphasized that the integration of physical stores and digital platforms, along with supply chain innovation, continues to strengthen Walmart’s business model and support future growth.

Source: Walmart
Walmart announced a major redesign of its flagship private label brand, Great Value, marking its first full refresh in over a decade.

The update introduces a modern visual identity aimed at improving product visibility and ease of shopping across both stores and digital platforms, while maintaining the same product quality and pricing. The redesign will cover nearly 10,000 items, making it the largest private brand update in the company’s history.

Walmart said the rollout will be phased over the next two years, starting with select product categories. The initiative is part of the retailer’s broader strategy to enhance customer experience and adapt to evolving consumer preferences, while continuing to emphasize affordability and consistency.

The company noted that Great Value products are present in most U.S. households and play a key role in delivering cost savings compared to national brands.
Walmart Inc. has launched a new business unit, Upstream Facility Services, expanding its in-house maintenance capabilities to serve external companies across the United States.

The new offering leverages Walmart’s extensive operational scale and expertise developed across its network of stores and Sam’s Club locations. Upstream will provide services including HVAC, refrigeration, electrical, plumbing, and general maintenance, targeting businesses with multi-location operations where uptime and efficiency are critical.

The service model combines urgent repairs, preventive maintenance, and predictive solutions, supported by a nationwide network of technicians positioned close to customer sites. Clients will also benefit from real-time visibility into service performance, enabling improved planning and faster decision-making.

With this move, Walmart aims to commercialize one of the largest in-house facility service operations in the country, helping businesses reduce downtime, extend asset life, and improve operational consistency.
Walmart Launches ‘The Devil Wears Prada’ Inspired Fashion Collection

Walmart has unveiled a limited-time “The Devil Wears Prada Scoop Collection,” bringing high-fashion inspiration to its affordable private-label lineup.

The collection, part of Walmart’s exclusive Scoop brand, draws on the iconic style of *The Devil Wears Prada* and features tailored blazers, structured dresses, denim sets, and statement accessories designed to reflect New York-inspired fashion trends.

Priced between $16 and $54, the range aims to deliver trend-forward styles at accessible price points. Pre-orders began on April 9 via Walmart*com, with a full launch scheduled for April 20 across online channels and select U.S. stores.

The release highlights Walmart’s ongoing strategy to expand its fashion offerings and appeal to style-conscious consumers seeking value-driven apparel.
Video Thumbnail
11-19-26The Investor
Video Thumbnail
10-15-26The Investor
Video Thumbnail
09-01-26European Investor
Video Thumbnail
08-20-26WS Investor
Video Thumbnail
08-20-26WS Investor

HKEX:9988

Post Image
Alibaba Slips 1.6% Premarket as Heavy AI Investment Overshadows Strong Cloud Growth

Alibaba Group (NYSE: BABA) shares fell 1.6% in premarket trading despite reporting strong September-quarter growth in cloud, earnings and AI-related revenue.

Quarterly revenue rose 10% year over year to RMB271.5 billion, while AI Cloud and Compute Services revenue increased 53%. External cloud revenue grew 64%, including 67% growth in recurring external revenue, and AI-related product revenue reached RMB17.9 billion, marking the thirteenth consecutive quarter of triple-digit growth.

Profitability improved sharply, with adjusted EBITA up 260% to RMB32.6 billion and non-GAAP net income up 92% to RMB19.9 billion. However, free cash flow remained deeply negative at RMB34.5 billion, compared with a RMB21.8 billion outflow a year earlier, as Alibaba accelerated spending on cloud infrastructure.

The 1.6% premarket decline appears to reflect concern over the cash cost of Alibaba’s AI buildout despite strong operating momentum. Capital expenditures rose 60% to RMB50.5 billion as the company expanded compute capacity and invested in chips and AI infrastructure, suggesting investors are balancing rapid cloud growth against materially heavier near-term capital intensity.
Alibaba Stock Falls 3% as Profit Slumps Despite Strong AI Cloud Growth

Alibaba Group (NYSE: BABA) shares fell about 3% Thursday after the company reported sharply lower quarterly earnings and heavy AI infrastructure spending, overshadowing strong revenue growth from its cloud business.

Profit Falls Sharply

June-quarter revenue increased 9% year over year to RMB268.95 billion. However, income from operations plunged 57%, while net income dropped 75% to RMB10.44 billion. Non-GAAP net income declined 38%, and non-GAAP diluted earnings per ADS fell 42% to RMB8.52.

Free cash flow was negative RMB44.67 billion, compared with negative RMB18.82 billion a year earlier, mainly due to increased cloud infrastructure spending.

AI Cloud Growth Remains a Major Positive

Alibaba's AI Cloud and Compute Services revenue reached RMB48.44 billion, with both total and external customer revenue growing 45%. AI-related product revenue reached RMB12.38 billion and posted triple-digit growth for the 12th consecutive quarter.

However, that growth requires substantial investment. Capital expenditures surged 75% to RMB67.68 billion as Alibaba expanded AI infrastructure and computing capacity.

Alibaba's 3% decline therefore appears primarily tied to the steep drop in earnings and heavier cash outflows. Strong AI and cloud growth remains encouraging, but investors appear concerned about the near-term cost of funding that expansion.
Video Thumbnail
02-23-26WS News
Video Thumbnail
09-24-25WS News

NASDAQ:SNPS

Barclays Initiates Synopsys at Overweight With $640 Price Target

Barclays initiated coverage of Synopsys (NASDAQ: SNPS) with an Overweight rating, with analyst Saket Kalia setting a $640 price target.

Synopsys shares are at $445.36, up 2.6%, following the initiation.

The $640 target implies substantial upside from the current share price and reflects a bullish initial view from Barclays.
Synopsys Slips 0.8% Premarket Despite Strong Q3 Results and Raised FY2026 Outlook

Synopsys (NASDAQ: SNPS) shares are down about 0.8% in premarket trading despite reporting stronger-than-expected fiscal third-quarter results and raising its full-year outlook as AI-related semiconductor design demand remains strong.

Revenue reached $2.477 billion, up sharply from $1.740 billion a year earlier, supported by broad-based strength and particularly strong performance in Design Automation. The recently acquired Ansys business also delivered a strong quarter, while Design IP returned to year-over-year growth.

Non-GAAP EPS came in at $3.91, above the high end of the company's previous guidance and up from $3.39 a year earlier. GAAP EPS increased to $2.84 from $1.50.

AI demand supports higher guidance

Management highlighted rising chip and system complexity from AI as a major demand driver for Synopsys' electronic design automation, silicon IP and engineering solutions.

Following the strong quarter, Synopsys raised its full-year revenue outlook to approximately $9.715 billion at the midpoint and non-GAAP EPS guidance to $15.07 at the midpoint. The company also increased expectations for operating margin and cash flow and expects double-digit growth in its EDA business.

The modest 0.8% premarket decline therefore does not appear to reflect fundamental weakness in the reported results. Instead, the muted reaction may indicate that investors had already priced in a strong quarter and AI-driven outlook, leaving the earnings beat and guidance increase insufficient to trigger another significant move higher.
Synopsys Expands AI Simulation Push Through Ansys-NVIDIA Omniverse Integration

Synopsys (NASDAQ: SNPS) is strengthening its position in AI-powered engineering simulation through an agreement between its Ansys business and NVIDIA to integrate NVIDIA Omniverse technology directly into Ansys simulation solutions.

The collaboration will initially bring Omniverse capabilities into Ansys computational fluid dynamics and autonomous-system applications, giving engineers access to NVIDIA’s simulation technologies and libraries directly through the Ansys interface.

Agreement Targets Physical AI and Digital Twins

The integration is designed to accelerate the development of physical AI, digital twins and autonomous systems by combining Ansys’ physics-based simulation capabilities with NVIDIA’s Omniverse platform.

Ansys will use OpenUSD to provide interoperability between different computer-aided engineering tools and Omniverse environments. This could be particularly valuable for large CFD workloads, where engineers need to analyze and visualize complex datasets while maintaining consistent workflows across multiple engineering applications.

For autonomous systems, the combination is intended to improve the development, training, testing and validation process. Automated scenario generation and exploration could allow engineers to evaluate autonomous technologies across a broader range of virtual conditions before real-world deployment.

Synopsys Strengthens Position Across AI Engineering Stack

The agreement also expands Synopsys’ exposure to one of the fastest-developing areas of the AI ecosystem: the transition from generative AI toward physical AI, where artificial intelligence interacts with and models real-world environments.

Following its acquisition of Ansys, Synopsys combines semiconductor design and electronic design automation expertise with advanced engineering simulation capabilities. Integrating NVIDIA Omniverse further connects those capabilities with accelerated computing, digital twins and AI-based simulation.

The partnership has potential applications across automotive engineering, aerospace, communications and other industries requiring high-fidelity physical simulation. The companies specifically highlighted applications ranging from vehicle aerodynamics and autonomous-vehicle safety to 6G connectivity.

PyAnsys Adds Another AI Integration Layer

The collaboration extends beyond visualization. PyAnsys, a collection of Python packages, allows customers to customize and automate simulations within applications built on NVIDIA Omniverse.

One example is PyAnsys-Heart, a digital twin of the human heart that combines simulation with a speech-to-text interface, illustrating how AI could make sophisticated engineering models accessible through more intuitive interfaces.

For Synopsys, the agreement reinforces the strategic rationale behind combining its existing silicon-to-systems portfolio with Ansys. The company is increasingly positioned at the intersection of semiconductor design, engineering simulation, digital twins and physical AI, while NVIDIA provides the accelerated computing and Omniverse infrastructure connecting these increasingly complex virtual engineering environments.
Synopsys Expands Physical AI Push as Ansys Integrates NVIDIA Omniverse

Synopsys (NASDAQ: SNPS) is expanding its physical AI and digital twin capabilities through Ansys, which announced an agreement with NVIDIA to embed NVIDIA Omniverse technology directly into its simulation solutions.

The integration will initially focus on Ansys’ computational fluid dynamics and autonomous-system products, giving engineers access to Omniverse capabilities directly within existing simulation workflows. The combination is designed to improve data preparation, interoperability and high-fidelity visualization while accelerating development and validation of autonomous systems.

Using OpenUSD, Ansys customers will be able to connect engineering simulation data with NVIDIA’s virtual-environment technologies. Potential applications include aerodynamics, autonomous vehicles, 6G connectivity and complex digital twins.

The agreement also expands the strategic relationship between Synopsys and NVIDIA around physical AI. Combining Ansys simulation technology with NVIDIA’s Omniverse platform could make it easier for companies to build physics-accurate virtual environments for training, testing and optimizing AI-driven physical systems.

For Synopsys, the integration strengthens the Ansys portfolio following its acquisition and increases the company’s exposure to growing demand for AI-enabled engineering simulation, digital twins and autonomous-system development.
Synopsys announced an expanded collaboration with TSMC to advance next-generation AI systems through enhanced silicon IP and AI-powered chip design tools. The partnership focuses on optimizing performance, power efficiency, and scalability across advanced semiconductor nodes, including 3nm and 2nm technologies.

The companies highlighted progress in high-speed connectivity solutions, including 224G and 64G interface technologies, as well as advancements in 3D chip design and co-packaged optics for data centers. AI-assisted design tools are also being integrated to improve productivity and accelerate chip development cycles.

The collaboration aims to support growing demand for high-performance computing and AI infrastructure by enabling faster, more efficient semiconductor innovation.

Source: PR Newswire
Synopsys Inc. is supporting NASA’s Artemis program by providing simulation tools to analyze spacesuit safety and develop lunar communication systems.

The work includes modeling spacesuit exposure to lunar conditions and testing antenna performance and cellular connectivity on the Moon using digital twin technology, helping reduce mission risks and improve astronaut safety.
Synopsys supports Arm’s new AGI CPU for next-generation AI data centers

March 24, 2026 — Synopsys announced its collaboration with Arm to support the development of the new Arm AGI CPU, providing full-stack design, IP, and verification solutions for advanced AI and high-performance computing workloads.

The partnership leverages Synopsys’ electronic design automation tools, silicon-proven interface IP, and hardware-assisted verification systems to optimize power, performance, and efficiency in the new data center processor.

Built on Arm’s Neoverse architecture, the AGI CPU targets next-generation AI infrastructure, requiring complex system validation and scalable design capabilities.

Synopsys said its solutions helped accelerate development, reduce integration risk, and enable faster time to market, reinforcing its role in advancing custom silicon innovation for AI-driven computing environments.
PRNewswire
Synopsys (SNPS) launched Ansys 2026 R1, introducing new AI-powered simulation and digital engineering capabilities that integrate Synopsys and Ansys technologies to streamline product development workflows.

The release combines generative AI, multiphysics simulation and digital twin technology to help engineering teams explore designs faster, automate complex processes and validate systems earlier in the development cycle. It also introduces new agentic AI tools, enhanced system-level engineering workflows and expanded digital twin capabilities for analyzing real-world performance.

Synopsys said the new platform aims to help companies design more complex AI-driven and software-defined systems more efficiently while reducing reliance on physical testing.

PRNewswire
Synopsys (SNPS) introduced new software-defined hardware-assisted verification (HAV) platforms and capabilities aimed at accelerating the development of increasingly complex AI chips used in data centers and edge devices.

The update includes new ZeBu and HAPS platforms, delivering up to 2x higher performance and capacity for large AI chip designs, as well as industry-first hardware-assisted test automation features designed to detect system-level and cache-coherency bugs earlier in the development cycle.

The company said the new verification technologies will help semiconductor firms validate AI processors faster and bring advanced silicon products to market more efficiently.

PRNewswire
Synopsys Initiates $250 Million Share Repurchase Agreement
Video Thumbnail
08-28-26The Investor
Video Thumbnail
12-02-25European Investor
Video Thumbnail
06-02-25WS News
Video Thumbnail
01-28-25WS Investor
Video Thumbnail
01-20-25WS Investor

NYSE:MRK

Merck Partners With Isomorphic Labs to Use AI in Oncology Drug Discovery

Merck (NYSE: MRK) entered a strategic research collaboration with Isomorphic Labs to discover small-molecule drug candidates against an oncology target, combining Merck’s proprietary data and drug-development expertise with Isomorphic Labs’ AI-based drug design platform.

Under the agreement, Isomorphic Labs will use its IsoDDE drug design engine and selected Merck data sets to make in silico predictions and design potential molecules. Merck will take responsibility for preclinical and clinical development, manufacturing and commercialization of any products that emerge from the collaboration.

Isomorphic Labs will receive an upfront payment and may earn additional research, development, regulatory and commercial milestone payments, as well as tiered royalties on future net sales. The company also has an option to co-fund development in exchange for higher royalties. Financial terms were not disclosed.

The partnership expands Merck’s use of AI in early-stage drug discovery and could help shorten molecule-design cycles by combining computational modeling with proprietary experimental data. However, the collaboration remains at the research stage, so any financial contribution would depend on successful candidate discovery, development and regulatory progress.
Merck Reports Positive Phase 2b Results for Efinopegdutide in MASH

Merck (NYSE: MRK) reported positive Phase 2b results for efinopegdutide, an investigational once-weekly GLP-1/glucagon receptor co-agonist being developed for adults with metabolic dysfunction-associated steatohepatitis, or MASH, and stage F2-F3 fibrosis.

The study met its primary endpoint, with MASH resolution without worsening of fibrosis achieved by 56%, 63% and 61% of patients receiving the 4 mg, 7 mg and 10 mg doses, respectively, compared with 13% for placebo at Week 52.

Efinopegdutide also showed improvement on the key secondary fibrosis endpoint. At least a one-stage improvement in fibrosis without worsening of steatohepatitis was seen in 43% of patients on 4 mg, 52% on 7 mg and 34% on 10 mg, versus 21% with placebo.

The safety profile was generally consistent with semaglutide, with gastrointestinal events including nausea, diarrhea and vomiting among the most common adverse effects. Discontinuation rates due to adverse events were 3%, 4% and 11% across the three efinopegdutide dose groups.

The Phase 2b trial enrolled 386 adults with biopsy-confirmed MASH and stage F2 or F3 fibrosis. Efinopegdutide has also received FDA Fast Track designation for the treatment of MASH.

The results strengthen Merck’s cardiometabolic pipeline by showing both disease-resolution and fibrosis benefits, although the program remains investigational and will require further development before any potential regulatory approval.
Merck’s Tulisokibart Meets Key Endpoints in Phase 2b Hidradenitis Suppurativa Study

Merck reported positive Phase 2b results for tulisokibart in patients with moderate to severe hidradenitis suppurativa, marking what the company described as the first positive Phase 2 data for an anti-TL1A monoclonal antibody in dermatology.

The study met its primary endpoint at week 16. HiSCR50 was achieved by 72% of patients receiving the high-dose regimen and 64% of those receiving the medium dose, compared with 35% for placebo. The low-dose group showed a 52% response rate in an exploratory analysis.

Key secondary measures also favored tulisokibart. HiSCR75 was reached by 41% of high-dose and 40% of medium-dose patients versus 15% with placebo, while quality-of-life scores also improved numerically in the higher-dose groups.

Safety was broadly comparable with placebo. Serious adverse events were infrequent, and no serious or opportunistic infections were reported.

Merck said the data will support advancement of tulisokibart into Phase 3 development for hidradenitis suppurativa. The drug is also being studied across several other immune-mediated inflammatory diseases, including ulcerative colitis, Crohn’s disease, rheumatoid arthritis and psoriatic arthritis.
Merck Licenses SciBrunch’s KRAS G12D Cancer Drug Candidate in Deal Worth Up to $2.13 Billion

Merck has entered into an exclusive global licensing agreement with SciBrunch Therapeutics for SPR2015, a preclinical oral KRAS G12D (ON) inhibitor targeting one of the most common cancer-driving mutations.

Under the agreement, Merck gains worldwide rights to develop, manufacture and commercialize SPR2015. SciBrunch will receive $400 million upfront and could earn additional development, commercialization and other milestone payments, bringing the total potential value of the deal to $2.13 billion.

SPR2015 is designed to selectively inhibit KRAS G12D, a mutation found across several major cancers, including pancreatic, colorectal and lung tumors. Preclinical data presented at the 2026 AACR Annual Meeting showed nanomolar antiproliferative activity in KRAS G12D-mutant cell lines and antitumor activity across multiple xenograft models.

The deal expands Merck’s precision oncology pipeline and gives the company another targeted approach beyond its established immuno-oncology franchise. Merck said the asset complements its growing portfolio of precision-targeted cancer candidates.

Merck will record a $400 million pre-tax charge related to the transaction in the third quarter of 2026, equal to about $0.13 per share on both a GAAP and non-GAAP basis.
FDA Updates Merck’s WINREVAIR Label With HYPERION Pulmonary Hypertension Data

Merck said the U.S. Food and Drug Administration approved an update to the label for WINREVAIR to include efficacy and safety data from the Phase 3 HYPERION trial in adults recently diagnosed with pulmonary arterial hypertension.

HYPERION enrolled patients diagnosed within the previous 12 months who were at intermediate to high risk of disease progression. Adding WINREVAIR to background therapy reduced the risk of clinical worsening events by 76% compared with placebo, with a hazard ratio of 0.24. A first clinical worsening event occurred in 10.6% of WINREVAIR-treated patients versus 36.9% of those receiving placebo.

The updated label provides additional evidence for using WINREVAIR earlier in the treatment pathway, rather than only later in the disease course. Most patients in HYPERION were already receiving double or triple background therapy, and the treatment effect was consistent across prespecified subgroups.

The FDA update also adds safety information from HYPERION. The most common adverse reactions included epistaxis, telangiectasia and increased hemoglobin, while treatment discontinuation due to adverse events occurred in 3% of WINREVAIR patients.

WINREVAIR is already approved for adults with pulmonary arterial hypertension to improve exercise capacity and functional class and reduce the risk of clinical worsening events. The new label strengthens Merck’s case for broader and earlier use of the drug in PAH care.
Merck’s KEYTRUDA QLEX Approved in Japan for All KEYTRUDA Indications

Merck said Japan’s Ministry of Health, Labor and Welfare approved KEYTRUDA QLEX for subcutaneous administration across all indications already approved in the country for intravenous KEYTRUDA.

In Japan, the product will be marketed under the planned name KEYJECT. It can be administered by a healthcare provider in about one minute every three weeks or two minutes every six weeks, making it the first and only subcutaneous immune checkpoint inhibitor available in Japan with administration as short as one minute.

The approval was supported by the Phase 3 MK-3475A-D77 study comparing subcutaneous KEYJECT with intravenous KEYTRUDA, both given every six weeks with chemotherapy in previously untreated metastatic non-small cell lung cancer. The study showed comparable pembrolizumab exposure, while response rates were 45% with KEYJECT plus chemotherapy and 42% with KEYTRUDA plus chemotherapy. No notable differences in progression-free or overall survival were observed.

Merck said the subcutaneous formulation could give patients and healthcare providers greater flexibility by allowing treatment in settings ranging from infusion centers to physician offices and community clinics.

KEYTRUDA QLEX is already approved in the U.S. for the same solid-tumor indications as KEYTRUDA, while subcutaneous pembrolizumab was approved in Europe in 2025.
Merck Wins Positive EU CHMP Opinion for KEYTRUDA-Padcev Bladder Cancer Regimen

Merck said the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of KEYTRUDA plus Padcev as perioperative treatment for adults with resectable muscle-invasive bladder cancer.

The recommendation covers use before surgery as neoadjuvant therapy and continued treatment after radical cystectomy as adjuvant therapy. A European Commission decision is expected by the fourth quarter of 2026. If approved, the combination would become the first PD-1 inhibitor plus antibody-drug conjugate regimen in the EU for patients with muscle-invasive bladder cancer regardless of cisplatin eligibility.

The CHMP opinion is based on the Phase 3 KEYNOTE-B15 trial. In cisplatin-eligible patients, KEYTRUDA plus Padcev reduced the risk of an event-free survival event by 47% versus neoadjuvant chemotherapy and surgery. The regimen also reduced the risk of death by 35% and produced a pathologic complete response rate of 55.8%, compared with 32.5% in the control group.

The combination is already approved in the U.S. for muscle-invasive bladder cancer regardless of cisplatin eligibility, while the EU previously approved it for cisplatin-ineligible patients.

The latest recommendation could broaden Merck’s position in earlier-stage bladder cancer and further expand KEYTRUDA’s role beyond advanced disease.
Merck Stock Rises 2.7% as Argus and Wolfe Research Raise Price Targets

Merck & Co. (NYSE: MRK) shares rose about 2.7% on Tuesday as two Wall Street firms raised their price targets on the pharmaceutical company while maintaining bullish ratings.

Argus analyst Jasper Hellweg raised the firm's price target on Merck to $170 from $145 while maintaining a Buy rating. Wolfe Research analyst Alexandria Hammond was even more bullish, increasing the firm's target to $180 from $155 and maintaining an Outperform rating.

With Merck trading around $154.73, the new targets imply upside of approximately 10% and 16%, respectively.

## Why the Rating Reports Are Positive for Merck

The simultaneous target increases from two firms signal improving expectations for Merck's earnings and valuation.

Merck remains one of the world's largest pharmaceutical companies, with a strong oncology franchise led by Keytruda and a broader pipeline designed to diversify growth over the longer term. The company's position in oncology and continued investment in new medicines remain central to its growth outlook.

Tuesday's 2.7% gain appears to reflect the positive analyst sentiment, with both firms seeing additional upside even after the stock's recent performance.
Moderna Soars 100%, Merck Jumps 10% After Landmark Phase 3 Cancer Vaccine Results

Moderna shares surged about 100% on Wednesday, while Merck climbed roughly 10%, after the companies announced positive Phase 3 results for their personalized mRNA cancer therapy intismeran autogene in combination with Merck’s blockbuster immunotherapy KEYTRUDA.

The INTerpath-001 trial met both its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival in patients with completely resected Stage IIB-IV melanoma. The combination produced statistically significant and clinically meaningful improvements compared with KEYTRUDA alone.

A Major Milestone for Moderna’s mRNA Platform

The results are particularly significant for Moderna because they represent the first positive Phase 3 readout for an individualized neoantigen therapy and the first positive Phase 3 study for an mRNA-based cancer therapy. The treatment is individually manufactured using mutations identified from each patient's tumor, with the resulting mRNA therapy designed to train the immune system to recognize and attack cancer cells.

That breakthrough likely explains the much larger reaction in Moderna shares. The results potentially validate the use of Moderna's mRNA technology beyond infectious-disease vaccines and provide important clinical validation for its oncology pipeline.

The companies also said no new safety signals were observed. They plan to present detailed data at an upcoming international medical meeting and share the results with regulatory authorities, opening the path toward potential filing submissions.

Merck Gains as KEYTRUDA Franchise Could Expand

For Merck, the results strengthen the long-term position of KEYTRUDA, its cornerstone cancer therapy. The combination is the first regimen to demonstrate statistically significant and clinically meaningful improvements in both recurrence-free and distant metastasis-free survival compared with KEYTRUDA alone in this adjuvant melanoma population.

Earlier Phase 2b data had already provided encouraging evidence: at five-year follow-up, the combination showed a 49% reduction in the risk of recurrence or death and a 59% reduction in the risk of distant metastasis or death compared with KEYTRUDA alone.

The companies are now studying intismeran across a broader oncology program encompassing nine Phase 2 and Phase 3 trials, including melanoma, non-small cell lung cancer, bladder cancer and renal cell carcinoma.

With Moderna up around 100% and Merck gaining about 10%, the market reaction reflects more than a single successful melanoma trial. Investors appear to be pricing in the possibility that personalized mRNA cancer therapies could become a new treatment platform, with potentially much broader applications if ongoing trials in other tumor types are successful.
Merck Stock Edges Higher as Strong Product Growth Offsets Acquisition Charge

Merck (NYSE: MRK) shares rose 0.54% on Tuesday after the pharmaceutical company reported solid second-quarter revenue growth, raised its full-year sales outlook and highlighted multiple regulatory and clinical milestones, despite posting a quarterly loss due to a one-time acquisition-related charge.

Second-quarter worldwide sales increased 5% year over year to $16.6 billion, driven by continued strength in oncology, animal health and recently launched products. The company reported a GAAP loss per share of $0.54 and a non-GAAP loss per share of $0.13, both primarily reflecting a $2.31 per share charge related to the acquisition of Terns Pharmaceuticals.

Oncology and New Product Launches Drive Revenue Growth

Merck's flagship cancer franchise remained the company's largest growth engine.

KEYTRUDA and the newly launched KEYTRUDA QLEX generated combined sales of $8.4 billion, up 5% from a year earlier, with KEYTRUDA QLEX contributing $463 million during its initial launch period.

WINREVAIR continued its rapid commercial expansion, with sales jumping 75% year over year to $588 million, while Animal Health revenue increased 8% to $1.8 billion, providing additional support for overall growth.

Pipeline Momentum and Higher Guidance

Beyond commercial performance, Merck reported several important pipeline achievements during the quarter.

The FDA approved LIPFENDRA, the first once-daily oral PCSK9 inhibitor for lowering LDL cholesterol, while the company also announced positive clinical data for its oncology and HIV programs, including a Phase 3 study evaluating a once-weekly oral HIV treatment developed with Gilead.

Reflecting continued business momentum, Merck narrowed and raised its full-year 2026 revenue guidance to between $66.3 billion and $67.3 billion. The company now expects non-GAAP EPS of $2.66 to $2.76, including the financial impact of the Terns acquisition.

What to Watch

Despite the acquisition-related accounting charge, investors appeared encouraged by Merck's underlying operating performance, growing contribution from recently launched medicines and continued pipeline progress. Going forward, markets will monitor the commercial rollout of KEYTRUDA QLEX and LIPFENDRA, continued growth of WINREVAIR, and additional regulatory and clinical milestones expected across Merck's expanding pipeline.
Video Thumbnail
10-26-26Global Finance News
Video Thumbnail
09-10-26WS News
Video Thumbnail
08-20-26WS Investor
Video Thumbnail
08-19-26WS News
Video Thumbnail
08-04-26European Investor

NASDAQ:FUTU

Futu Jumps 6% as Account Growth and Trading Activity Offset Margin Pressure

Futu Holdings (NASDAQ: FUTU) shares rose 6% after the online brokerage reported strong client growth, higher trading activity and resilient profitability despite softer market conditions.

Funded accounts increased 27.9% year over year to 4.01 million, while total trading volume rose 28.4% to HK$5.01 trillion. Revenue increased 4.5% to HK$6.69 billion, and operating income rose 3.5% to HK$4.04 billion.

Growth in wealth management was another positive, with client assets in the segment increasing 11.8% year over year to HK$196.4 billion and penetration rising to 28.2%. International markets, particularly Malaysia, Singapore and Hong Kong, continued to drive new account additions.

The 6% gain appears to reflect confidence in Futu’s customer acquisition, international expansion and wealth-management diversification. However, gross margin fell to 84.2% from 87.6% as costs rose faster than revenue, while adjusted net income was broadly flat, suggesting the market is rewarding growth in the platform rather than a major near-term earnings acceleration.
JPMorgan Cuts Futu Price Target to $103, Maintains Neutral Rating

JPMorgan lowered its price target on Futu Holdings (NASDAQ: FUTU) to $103 from $122 while maintaining a Neutral rating on the stock.

Analyst Katherine Lei issued the revised target as Futu shares traded at $83.68, down 3.7%.

The new $103 target still implies upside from the current share price, but the lower target indicates a more cautious valuation view from JPMorgan.
Futu Stock Edges Up 0.6% as Q2 Profit Jumps 42% on Record Trading Activity

Futu Holdings (NASDAQ: FUTU) shares rose about 0.6% Thursday after the online brokerage reported strong second-quarter growth, including record trading volume and sharply higher earnings.

Revenue and Profit Surge

Second-quarter revenue increased 35.6% year over year to HK$7.20 billion, while net income jumped 41.6% to HK$3.64 billion. Adjusted net income rose 40.1% to HK$3.73 billion.

Trading activity was particularly strong, with total volume surging 78.8% to a record HK$6.42 trillion, driven largely by increased U.S. stock trading in semiconductor and AI-related names.

Funded accounts increased 33.6% to 3.84 million, while total client assets climbed 43.6% to HK$1.40 trillion.

Despite the strong growth, gross margin slipped to 86.3% from 87.4%, while operating expenses increased 35.1%, including a 53.1% rise in marketing expenses.

Overall, strong trading activity, customer growth and a 42% increase in net income appear to be supporting FUTU shares, while higher expenses and modest margin compression may be limiting the stock's gain.

NYSE:IP

Argus Downgrades International Paper to Hold

Argus downgraded International Paper (NYSE: IP) to Hold from Buy, with analyst Alexandra Yates issuing the rating change.

International Paper shares are at $31.32, down 3.7%.

The downgrade signals a more cautious stance on the stock.
International Paper Reports Q3 2025 Loss Amid Transformation and Mill Closures

International Paper (NYSE: IP; LSE: IPC) reported a third-quarter 2025 loss from continuing operations of $426 million, or $(0.81) per share, compared with earnings of $75 million in the prior quarter. Adjusted operating loss was $224 million, or $(0.43) per share. The results included $675 million in accelerated depreciation linked to mill closures and strategic restructuring under the company’s “80/20” transformation plan.

Net sales were $6.2 billion, up slightly from $6.1 billion in Q2 2025. Adjusted EBITDA from continuing operations rose to $859 million from $670 million in the prior quarter, reflecting a 28% sequential improvement across Packaging Solutions, driven by better pricing, cost control, and lower fiber costs. Free cash flow was $150 million compared with $54 million in Q2.

Chairman and CEO Andy Silvernail said the company is “reshaping its portfolio” by exiting non-core operations and reinvesting in strategic assets. He noted that North American box shipments rose year over year in September, signaling early progress in narrowing the industry demand gap.

International Paper also reported a total net loss of $1.1 billion for the quarter, which includes a $676 million after-tax loss from discontinued operations following the classification of its Global Cellulose Fibers business as discontinued. The company reaffirmed its focus on achieving an advantaged cost position and sustainable growth as it continues to execute its transformation plan.
International Paper Q1 2025 Financial Summary

- Net sales: $5.9 billion (up from $4.6 billion in Q1 2024)
- Net loss: $105 million or $0.24 per share
- Adjusted operating earnings: $101 million or $0.23 per share
- Free cash flow: negative $618 million (compared to $144 million in Q1 2024)
- Cash used in operations: negative $288 million (compared to $395 million provided in Q1 2024)

Key Drivers and Events

- The company recorded a $271 million pre-tax charge due to accelerated depreciation and restructuring related to the Red River mill closure.
- The acquisition of DS Smith contributed significantly to sales growth but also added to transaction and integration costs.
- A large portion of cash outflow was due to $670 million in transformation and incentive compensation expenses.
- Higher capital expenditures were in line with 2025 strategic investments.
- The company received insurance reimbursements and proceeds from asset sales to partially offset cash usage.

Segment Performance

- Packaging Solutions North America: $3.7 billion in sales, $142 million in operating profit
- Packaging Solutions EMEA: $1.55 billion in sales, $46 million in operating profit
- Global Cellulose Fibers: $643 million in sales, $17 million in operating profit

Special Items (after-tax impact)

- DS Smith combination and integration costs: $183 million
- Severance and restructuring costs: $63 million
- Gain on sale of assets: $51 million
- Total net special charges: $204 million

Balance Sheet Snapshot as of March 31, 2025

- Total assets: $41.2 billion (up from $22.8 billion at year-end 2024)
- Total debt: $9.6 billion
- Total equity: $18.1 billion
- Cash and equivalents: $1.16 billion
International Paper Hosts Investor Day, Shares Strategic Vision

On March 25, 2025, International Paper Company held its Investor Day event in New York City, presenting its long-term strategic direction and operational goals. The company's leadership team discussed initiatives aimed at enhancing value creation and sustainable growth. The webcast and presentation materials were made available on International Paper's investor relations website, with a replay accessible within 24 hours.

The event underscored the company’s commitment to innovation, operational efficiency, and shareholder returns. A press release related to the event was filed as Exhibit 99.1 to the company's latest Form 8-K.
International Paper Completes Consent Solicitation and Assumes Guarantee for DS Smith’s Debt Securities
Memphis, TN – March 11, 2025 – International Paper Company (NYSE: IP, LSE: IPC) announced the successful completion of its Consent Solicitation process concerning DS Smith Limited’s outstanding €2.35 billion and £250 million in debt securities. As a result, International Paper has formally assumed the guarantee of DS Smith’s payment obligations.

Key Transaction Highlights:
Consent Solicitation Approved:
Debt holders approved modifications to DS Smith’s Euro-Medium Term Note Programme.
Changes align events of default and reporting requirements with International Paper’s debt structure.
Guarantee Assumption by International Paper:
Effective March 10, 2025, International Paper guarantees all four series of DS Smith’s outstanding notes:
€600M 0.875% Notes due 2026
€850M 4.375% Notes due 2027
£250M 2.875% Notes due 2029
€650M 4.500% Notes due 2030
Supplemental Trust Deeds Executed:
Changes were formalized via Supplemental Trust Deeds and a Deed of Guarantee.
Strategic Implications:
This transaction strengthens International Paper’s financial backing for DS Smith and increases operational flexibility within the group. It also enhances debt management by aligning DS Smith’s debt obligations with International Paper’s financial policies and credit structure.

For further details, refer to the Supplemental Trust Deed filed with the Securities and Exchange Commission (SEC) as an Exhibit to International Paper’s Form 8-K.
**International Paper Announces Leadership Changes**

International Paper Company has announced key executive changes, as disclosed in a Form 8-K filing with the SEC.

Timothy S. Nicholls has been appointed executive vice president and president of DS Smith, an International Paper company, effective April 1, 2025. In this newly created role, he will lead the company’s business in Europe, the Middle East, and Africa (EMEA), overseeing operations and integration efforts. Nicholls has been with International Paper since 1999 and has served as chief financial officer twice. He will continue reporting to CEO and Chairman Andrew K. Silvernail.

Lance T. Loeffler has been named senior vice president and chief financial officer, succeeding Nicholls, effective April 1, 2025. Loeffler joins International Paper from Halliburton, where he held multiple leadership roles, including CFO. His employment includes a base salary of $850,000, a target annual bonus equal to 100% of his salary, and a one-time inducement grant of restricted stock units valued at $1.7 million. He will also participate in the company’s Long-Term Incentive Plan, with a 2025 performance stock unit grant valued at $3.5 million.

The company issued a press release on February 28, 2025, announcing these appointments.
International Paper Company announced the publication of a supplementary prospectus related to its acquisition of DS Smith Plc. The acquisition, an all-stock transaction, was completed on January 31, 2025. The supplementary prospectus, issued under U.K. Financial Conduct Authority regulations, provides additional details regarding the listing of International Paper’s common stock on the London Stock Exchange.
International Paper Company completed its acquisition of DS Smith plc on January 31, 2025, through a court-sanctioned scheme of arrangement under UK law. DS Smith shareholders received 0.1285 shares of International Paper common stock for each DS Smith share, resulting in the issuance of approximately 179.85 million new shares. DS Smith's shares will be delisted from the London Stock Exchange on February 4, 2025, while International Paper's shares will begin secondary trading on the LSE under the symbol “IPC.” The acquisition increases International Paper’s outstanding share capital by approximately 34.1%. A press release announcing the completion of the acquisition was issued the same day.
International Paper reported full-year 2024 net earnings of $557 million, or $1.57 per diluted share, with adjusted operating earnings of $400 million, or $1.13 per share. Net sales for the year were $18.6 billion, slightly down from $18.9 billion in 2023. The fourth quarter resulted in a net loss of $147 million, or $0.42 per share, with an adjusted operating loss of $7 million, or $0.02 per share. Fourth-quarter net sales were $4.6 billion, unchanged from the prior year.

Full-year results were impacted by a $395 million pre-tax charge for accelerated depreciation and restructuring, including $334 million related to the closure of the Georgetown, South Carolina pulp mill. CEO Andy Silvernail emphasized the company’s strategic focus on cost reductions, corporate restructuring, and optimizing its packaging operations. He noted that 2025 will be a transformational year with efforts to balance capacity, reduce costs, and improve profitability, including the planned acquisition of DS Smith.

Industrial Packaging reported fourth-quarter operating profit of $247 million, up from $197 million in the previous quarter, driven by cost savings and an insurance reimbursement. Global Cellulose Fibers posted a $250 million loss, primarily due to lower sales prices, higher operating costs, and a $215 million charge from the Georgetown mill closure.

Cash provided by operations was $1.7 billion in 2024, down from $1.8 billion in 2023, while free cash flow increased to $757 million from $692 million. The company reduced debt, maintained its dividend payments, and continued capital investments of $921 million for the year.

International Paper is also evaluating strategic options for its Global Cellulose Fibers business. The company will host a webcast to discuss earnings and market conditions, with details available on its investor website.
Video Thumbnail
05-14-25Global Finance News